Market closedADR

Belite Bio Inc. ADS/$BLTE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Belite Bio Inc. ADS

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Ticker

$BLTE
Trading on

Industry

Pharmaceuticals

Employees

25

BLTE Metrics

BasicAdvanced
$2.1B
-
-$1.18
-1.54
-
$2.1B
-1.54
$70.99
$54.28
24.31
24.087
0.179
0.368
-1,999.80%
-20.26%
-30.60%
14.19
14.19
-67.551
-0.50%
5.43%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BLTE

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Belite Bio Inc. ADS stock?

Belite Bio Inc. ADS (BLTE) has a market cap of $2.1B as of April 03, 2025.

What is the P/E ratio for Belite Bio Inc. ADS stock?

The price to earnings (P/E) ratio for Belite Bio Inc. ADS (BLTE) stock is 0 as of April 03, 2025.

Does Belite Bio Inc. ADS stock pay dividends?

No, Belite Bio Inc. ADS (BLTE) stock does not pay dividends to its shareholders as of April 03, 2025.

When is the next Belite Bio Inc. ADS dividend payment date?

Belite Bio Inc. ADS (BLTE) stock does not pay dividends to its shareholders.

What is the beta indicator for Belite Bio Inc. ADS?

Belite Bio Inc. ADS (BLTE) has a beta rating of -1.54. This means that it has an inverse relation to market volatility.